Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

PBAX

Phoenix Biotech Aquisition (PBAX)

Phoenix Biotech Aquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PBAX
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202422h48Business WirePhoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
07/06/202312h05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/06/202315h27Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/06/202314h00Business WireCERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell TherapeuticsNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/05/202322h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
24/03/202311h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/02/202321h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/02/202319h52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/02/202312h11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
25/01/202313h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
20/12/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
07/12/202222h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
07/12/202222h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
21/11/202214h39Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
10/11/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
04/11/202221h07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
31/10/202214h29Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
31/10/202214h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/08/202222h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
13/05/202222h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
24/03/202221h13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/02/202222h51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
08/02/202222h06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
03/02/202214h22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
22/11/202122h15GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
08/10/202122h00GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment OptionNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/10/202123h19GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public OfferingNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAX

Kürzlich von Ihnen besucht

Delayed Upgrade Clock